Chemoresistance in breast cancer: PI3K/Akt pathway inhibitors vs the current chemotherapy
Breast cancer is the most prevalent type of cancer among women. Several types of drugs, targeting the specific proteins expressed on the breast cancer cell surface (such as receptor tyrosine kinases and immune checkpoint regulators) and proteins involved in cell cycle and motility (including cyclin-...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Published: |
e-Century Publishing
2021
|